Intravitreal Bevacizumab for Refractory Pseudophakic Cystoid Macular Edema The Pan-American Collaborative Retina Study Group Results

Objective: To determine the feasibility, safety, and clinical effect of intravitreal (IVT) bevacizumab (Avastin; Genentech, Inc., San Francisco, CA) in patients with refractory cystoid macular edema (CME) after cataract surgery. Design: Interventional, retrospective, multicenter study.

Autores:
Tipo de recurso:
Fecha de publicación:
2009
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/26147
Acceso en línea:
https://doi.org/10.1016/j.ophtha.2009.04.006
https://repository.urosario.edu.co/handle/10336/26147
Palabra clave:
Aged
Aged
80 and over
Angiogenesis Inhibitors
Antibodies
Monoclonal
Antibodies
Monoclonal
Humanized
Bevacizumab
Cataract Extraction
Feasibility Studies
Female
Fluorescein Angiography
Follow-Up Studies
Humans
Injections
Macular Edema
Male
Postoperative Complications
Pseudophakia
Retrospective Studies
Tomography
Optical Coherence
Treatment Outcome
Vascular Endothelial Growth Factor A
Visual Acuity
Vitreous Body
Rights
License
Restringido (Acceso a grupos específicos)
id EDOCUR2_d8f3d52296795aead265cb61861fb054
oai_identifier_str oai:repository.urosario.edu.co:10336/26147
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling 739ecf4c-3887-4668-bcea-2114906b5010-1c4f0daa5-b76d-47f4-bec5-e92a853049b8-15e73b0b0-f241-40ab-a7bf-65cf76736d48-17fe3703f-ddb2-4ce2-b045-4212aa98c927-1e69e8b13-e9f7-4381-a9a8-95e96943618f-1390567f2-51a9-42ab-b5cb-bca59742d357-1e9382a84-7532-4238-a6e9-d0b1e9cc130f-12020-08-06T16:20:47Z2020-08-06T16:20:47Z2009-06-22Objective: To determine the feasibility, safety, and clinical effect of intravitreal (IVT) bevacizumab (Avastin; Genentech, Inc., San Francisco, CA) in patients with refractory cystoid macular edema (CME) after cataract surgery. Design: Interventional, retrospective, multicenter study.application/pdfhttps://doi.org/10.1016/j.ophtha.2009.04.006ISSN: 1549-4713EISSN: 0161-6420https://repository.urosario.edu.co/handle/10336/26147engElsevier1487No. 81481OphthalmologyVol. 116Ophthalmology, ISSN: 1096-1208 ; EISSN: 0882-4010, Vol.116, No.8 (August, 2009); pp.1481-1487https://www.aaojournal.org/article/S0161-6420(09)00358-3/fulltextRestringido (Acceso a grupos específicos)http://purl.org/coar/access_right/c_16ecOphthalmologyinstname:Universidad del Rosarioreponame:Repositorio Institucional EdocURAgedAged80 and overAngiogenesis InhibitorsAntibodiesMonoclonalAntibodiesMonoclonalHumanizedBevacizumabCataract ExtractionFeasibility StudiesFemaleFluorescein AngiographyFollow-Up StudiesHumansInjectionsMacular EdemaMalePostoperative ComplicationsPseudophakiaRetrospective StudiesTomographyOptical CoherenceTreatment OutcomeVascular Endothelial Growth Factor AVisual AcuityVitreous BodyIntravitreal Bevacizumab for Refractory Pseudophakic Cystoid Macular Edema The Pan-American Collaborative Retina Study Group ResultsBevacizumab intravítreo para el edema macular cistoide pseudofáquico refractario Resultados del grupo de estudio de la retina colaborativa panamericanaarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Arevalo, J. FernandoMaia, MauricioGarcia-Amaris, Rafael A.Roca, Jose A.Sanchez, Juan G.Berrocal, Maria H.Wu, Lihteh10336/26147oai:repository.urosario.edu.co:10336/261472022-05-02 07:37:21.812133https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv Intravitreal Bevacizumab for Refractory Pseudophakic Cystoid Macular Edema The Pan-American Collaborative Retina Study Group Results
dc.title.TranslatedTitle.spa.fl_str_mv Bevacizumab intravítreo para el edema macular cistoide pseudofáquico refractario Resultados del grupo de estudio de la retina colaborativa panamericana
title Intravitreal Bevacizumab for Refractory Pseudophakic Cystoid Macular Edema The Pan-American Collaborative Retina Study Group Results
spellingShingle Intravitreal Bevacizumab for Refractory Pseudophakic Cystoid Macular Edema The Pan-American Collaborative Retina Study Group Results
Aged
Aged
80 and over
Angiogenesis Inhibitors
Antibodies
Monoclonal
Antibodies
Monoclonal
Humanized
Bevacizumab
Cataract Extraction
Feasibility Studies
Female
Fluorescein Angiography
Follow-Up Studies
Humans
Injections
Macular Edema
Male
Postoperative Complications
Pseudophakia
Retrospective Studies
Tomography
Optical Coherence
Treatment Outcome
Vascular Endothelial Growth Factor A
Visual Acuity
Vitreous Body
title_short Intravitreal Bevacizumab for Refractory Pseudophakic Cystoid Macular Edema The Pan-American Collaborative Retina Study Group Results
title_full Intravitreal Bevacizumab for Refractory Pseudophakic Cystoid Macular Edema The Pan-American Collaborative Retina Study Group Results
title_fullStr Intravitreal Bevacizumab for Refractory Pseudophakic Cystoid Macular Edema The Pan-American Collaborative Retina Study Group Results
title_full_unstemmed Intravitreal Bevacizumab for Refractory Pseudophakic Cystoid Macular Edema The Pan-American Collaborative Retina Study Group Results
title_sort Intravitreal Bevacizumab for Refractory Pseudophakic Cystoid Macular Edema The Pan-American Collaborative Retina Study Group Results
dc.subject.keyword.spa.fl_str_mv Aged
Aged
80 and over
Angiogenesis Inhibitors
Antibodies
Monoclonal
Antibodies
Monoclonal
Humanized
Bevacizumab
Cataract Extraction
Feasibility Studies
Female
Fluorescein Angiography
Follow-Up Studies
Humans
Injections
Macular Edema
Male
Postoperative Complications
Pseudophakia
Retrospective Studies
Tomography
Optical Coherence
Treatment Outcome
Vascular Endothelial Growth Factor A
Visual Acuity
Vitreous Body
topic Aged
Aged
80 and over
Angiogenesis Inhibitors
Antibodies
Monoclonal
Antibodies
Monoclonal
Humanized
Bevacizumab
Cataract Extraction
Feasibility Studies
Female
Fluorescein Angiography
Follow-Up Studies
Humans
Injections
Macular Edema
Male
Postoperative Complications
Pseudophakia
Retrospective Studies
Tomography
Optical Coherence
Treatment Outcome
Vascular Endothelial Growth Factor A
Visual Acuity
Vitreous Body
description Objective: To determine the feasibility, safety, and clinical effect of intravitreal (IVT) bevacizumab (Avastin; Genentech, Inc., San Francisco, CA) in patients with refractory cystoid macular edema (CME) after cataract surgery. Design: Interventional, retrospective, multicenter study.
publishDate 2009
dc.date.created.spa.fl_str_mv 2009-06-22
dc.date.accessioned.none.fl_str_mv 2020-08-06T16:20:47Z
dc.date.available.none.fl_str_mv 2020-08-06T16:20:47Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1016/j.ophtha.2009.04.006
dc.identifier.issn.none.fl_str_mv ISSN: 1549-4713
EISSN: 0161-6420
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/26147
url https://doi.org/10.1016/j.ophtha.2009.04.006
https://repository.urosario.edu.co/handle/10336/26147
identifier_str_mv ISSN: 1549-4713
EISSN: 0161-6420
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 1487
dc.relation.citationIssue.none.fl_str_mv No. 8
dc.relation.citationStartPage.none.fl_str_mv 1481
dc.relation.citationTitle.none.fl_str_mv Ophthalmology
dc.relation.citationVolume.none.fl_str_mv Vol. 116
dc.relation.ispartof.spa.fl_str_mv Ophthalmology, ISSN: 1096-1208 ; EISSN: 0882-4010, Vol.116, No.8 (August, 2009); pp.1481-1487
dc.relation.uri.spa.fl_str_mv https://www.aaojournal.org/article/S0161-6420(09)00358-3/fulltext
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_16ec
dc.rights.acceso.spa.fl_str_mv Restringido (Acceso a grupos específicos)
rights_invalid_str_mv Restringido (Acceso a grupos específicos)
http://purl.org/coar/access_right/c_16ec
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Elsevier
dc.source.spa.fl_str_mv Ophthalmology
institution Universidad del Rosario
dc.source.instname.none.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.none.fl_str_mv reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1814167446598189056

Publicaciones similares